Extendicare（5XE）株式概要Extendicare Inc.はその子会社を通じて、カナダで高齢者向けのケアとサービスを提供している。 詳細5XE ファンダメンタル分析スノーフレーク・スコア評価1/6将来の成長1/6過去の実績4/6財務の健全性3/6配当金5/6報酬収益は年間11.34%増加すると予測されています 過去1年間で収益は45.8%増加しました 1.63%の安定した配当金を支払う アナリストらは、株価が22.2%上昇するだろうとほぼ一致している。 リスク分析多額の負債を抱えている 過去3か月間に大規模なインサイダー売却が発生 すべてのリスクチェックを見る5XE Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.NEW483,572 membersJoin community and earn perksGain real feedbackFrom our editorial team, personally. Not silence.Grow your followingReal investors. The kind who actually invest, not scroll past.Unlock free accessFree premium subscription for consistent and quality authors.Learn moreCreate NarrativeBLINRODA483,572 investors already sharing narrativesYour Fair Value€Current Price€20.2012.0% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture03b2016201920222025202620282031Revenue CA$3.2bEarnings CA$198.4mAdvancedSet Fair ValueView all narrativesExtendicare Inc. 競合他社RHÖN-KLINIKUMSymbol: XTRA:RHKMarket cap: €1.0bM1 KlinikenSymbol: XTRA:M12Market cap: €356.6mLIMES SchlossklinikenSymbol: XTRA:LIKMarket cap: €172.8mMEDICLINSymbol: XTRA:MEDMarket cap: €204.3m価格と性能株価の高値、安値、推移の概要Extendicare過去の株価現在の株価CA$20.4052週高値CA$24.0052週安値CA$7.90ベータ1.151ヶ月の変化-8.93%3ヶ月変化5.15%1年変化150.31%3年間の変化330.38%5年間の変化288.57%IPOからの変化270.91%最新ニュースNew Risk • Aug 07New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 136% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (136% net debt to equity). Significant insider selling over the past 3 months (€4.2m sold).Reported Earnings • Aug 07Second quarter 2026 earnings released: EPS: CA$0.32 (vs CA$0.38 in 2Q 2025)Second quarter 2026 results: EPS: CA$0.32 (down from CA$0.38 in 2Q 2025). Revenue: CA$611.0m (up 59% from 2Q 2025). Net income: CA$30.9m (down 3.4% from 2Q 2025). Profit margin: 5.0% (down from 8.3% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 61% per year, which means it is tracking significantly ahead of earnings growth.Declared Dividend • Jul 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 31st July 2026 Payment date: 17th August 2026 Dividend yield will be 1.4%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jul 16Extendicare Announces July 2026 Dividend, Payable on August 17, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).お知らせ • Jul 07Extendicare Inc. to Report Q2, 2026 Results on Aug 06, 2026Extendicare Inc. announced that they will report Q2, 2026 results After-Market on Aug 06, 2026Declared Dividend • Jun 25Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.6%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.最新情報をもっと見るRecent updatesNew Risk • Aug 07New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 136% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (136% net debt to equity). Significant insider selling over the past 3 months (€4.2m sold).Reported Earnings • Aug 07Second quarter 2026 earnings released: EPS: CA$0.32 (vs CA$0.38 in 2Q 2025)Second quarter 2026 results: EPS: CA$0.32 (down from CA$0.38 in 2Q 2025). Revenue: CA$611.0m (up 59% from 2Q 2025). Net income: CA$30.9m (down 3.4% from 2Q 2025). Profit margin: 5.0% (down from 8.3% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 61% per year, which means it is tracking significantly ahead of earnings growth.Declared Dividend • Jul 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 31st July 2026 Payment date: 17th August 2026 Dividend yield will be 1.4%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jul 16Extendicare Announces July 2026 Dividend, Payable on August 17, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).お知らせ • Jul 07Extendicare Inc. to Report Q2, 2026 Results on Aug 06, 2026Extendicare Inc. announced that they will report Q2, 2026 results After-Market on Aug 06, 2026Declared Dividend • Jun 25Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.6%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Jun 15Extendicare Inc. Declares Cash Dividend for the Month of June 2026, Payable on July 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026.Declared Dividend • May 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 29th May 2026 Payment date: 15th June 2026 Dividend yield will be 1.6%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • May 09Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Apr 17+ 1 more updateExtendicare Inc. Announces April 2026 Cash Dividend, Payable on May 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of April 2026, which is payable on May 15, 2026 to shareholders of record at the close of business on April 30, 2026.お知らせ • Apr 06Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026お知らせ • Mar 19Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-ElectionExtendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate.お知らせ • Feb 27Extendicare Inc. Increases Cash Dividend for the Month of March 2026Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases.お知らせ • Feb 17Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Jan 27Extendicare Inc., Annual General Meeting, Apr 16, 2026Extendicare Inc., Annual General Meeting, Apr 16, 2026.お知らせ • Jan 16Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026お知らせ • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Dec 13Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Nov 20Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million.Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million. For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million. The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share. CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health.お知らせ • Nov 13Extendicare Inc. announces Monthly dividend, payable on December 15, 2025Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025.お知らせ • Oct 15Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Oct 07Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025お知らせ • Sep 15Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025.お知らせ • Aug 07Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.お知らせ • Jul 15Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Jul 07Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025お知らせ • Jun 18Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Jun 03Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc.Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction. Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025.お知らせ • May 07Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025.お知らせ • Apr 16Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).お知らせ • Apr 03Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025お知らせ • Mar 18Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Mar 17Extendicare Inc., Annual General Meeting, May 27, 2025Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canadaお知らせ • Feb 28+ 1 more updateExtendicare Inc. Announces Dividend IncreaseExtendicare Inc. announced improved performance and growth in all three business segments has resulted in the dividend payout ratio dropping below 50%. Accordingly, the Company will increase its dividend by 5.0% to 4.2 cents per month effective with the dividend to be declared in March 2025.お知らせ • Feb 14Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025.お知らせ • Jan 13Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025お知らせ • Dec 13Extendicare Announces December 2024 Dividend, Payable on January 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).Reported Earnings • Nov 14Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023)Third quarter 2024 results: EPS: CA$0.20 (up from CA$0.14 in 3Q 2023). Revenue: CA$359.1m (up 11% from 3Q 2023). Net income: CA$16.3m (up 38% from 3Q 2023). Profit margin: 4.5% (up from 3.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.お知らせ • Nov 13Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.Declared Dividend • Oct 18Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st October 2024 Payment date: 15th November 2024 Dividend yield will be 5.5%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Oct 15Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Oct 04Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024Declared Dividend • Sep 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 5.7%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.お知らせ • Sep 16Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).Declared Dividend • Aug 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 30th August 2024 Payment date: 16th September 2024 Dividend yield will be 6.4%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Reported Earnings • Aug 13Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023)Second quarter 2024 results: EPS: CA$0.30 (up from CA$0.023 in 2Q 2023). Revenue: CA$348.5m (up 13% from 2Q 2023). Net income: CA$25.9m (up CA$23.9m from 2Q 2023). Profit margin: 7.4% (up from 0.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.Declared Dividend • Jul 22Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st July 2024 Payment date: 15th August 2024 Dividend yield will be 6.9%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.お知らせ • Jul 15Extendicare Inc. Announces July 2024 Cash Dividend, Payable on August 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of July 2024, which is payable on August 15, 2024 to shareholders of record at the close of business on July 31, 2024.お知らせ • Jul 06Extendicare Inc. to Report Q2, 2024 Results on Aug 12, 2024Extendicare Inc. announced that they will report Q2, 2024 results After-Market on Aug 12, 2024Recent Insider Transactions • Jul 05Senior Vice President of ParaMed & CTO recently bought €67k worth of stockOn the 28th of June, Steve Paraskevopoulos bought around 14k shares on-market at roughly €4.93 per share. This transaction amounted to 45% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €135k more in shares than they have sold in the last 12 months.Declared Dividend • Jun 24Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 28th June 2024 Payment date: 15th July 2024 Dividend yield will be 7.0%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.お知らせ • Jun 18Extendicare Inc. Declares Cash Dividend for the Month of June 2024, Payable on July 15, 2024Extendicare Inc. announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of June 2024, which is payable on July 15, 2024 to shareholders of record at the close of business on June 28, 2024.お知らせ • May 24Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A DirectorExtendicare Inc. at the annual meeting of shareholders held on May 23, 2024 announced that Alan Hibben did not receive a majority of votes in favour at the Meeting and thus has not been re-elected as a director of Extendicare and resigned as such effective at the end of the Meeting.Declared Dividend • May 20Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st May 2024 Payment date: 17th June 2024 Dividend yield will be 7.1%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (115% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.Reported Earnings • May 17First quarter 2024 earnings released: EPS: CA$0.16 (vs CA$0.14 in 1Q 2023)First quarter 2024 results: EPS: CA$0.16 (up from CA$0.14 in 1Q 2023). Revenue: CA$367.1m (up 13% from 1Q 2023). Net income: CA$13.1m (up 13% from 1Q 2023). Profit margin: 3.6% (in line with 1Q 2023). Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.お知らせ • May 17Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of May 2024, which is payable on June 17, 2024, to shareholders of record at the close of business on May 31, 2024.Upcoming Dividend • Apr 25Upcoming dividend of CA$0.04 per shareEligible shareholders must have bought the stock before 29 April 2024. Payment date: 15 May 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.6%. Within top quartile of German dividend payers (4.8%). Higher than average of industry peers (2.9%).Declared Dividend • Apr 23Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 29th April 2024 Payment date: 15th May 2024 Dividend yield will be 7.1%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (120% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 33% to bring the payout ratio under control, which is less than the 35% EPS growth achieved over the last 5 years.お知らせ • Apr 21Extendicare Inc., Annual General Meeting, May 23, 2024Extendicare Inc., Annual General Meeting, May 23, 2024, at 10:30 Eastern Daylight. Location: TMX Market Centre, 120 Adelaide Street West, Toronto Ontario Canada Agenda: To consider to receive the consolidated financial statements of the Company for the year ended December 31, 2023 and the report of the auditors thereon; to appoint the auditors of the Company and authorize the directors to fix the auditors remuneration; to elect the directors of the Company; to approve an advisory (non-binding) resolution to accept the approach of the Company to executive compensation disclosed in the Information Circular; and to discuss other matters.お知らせ • Apr 15Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Apr 05Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024Extendicare Inc. announced that they will report Q1, 2024 results After-Market on May 15, 2024Upcoming Dividend • Mar 20Upcoming dividend of CA$0.04 per shareEligible shareholders must have bought the stock before 27 March 2024. Payment date: 15 April 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.2%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.1%).Declared Dividend • Mar 18Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 27th March 2024 Payment date: 15th April 2024 Dividend yield will be 7.0%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (120% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 33% to bring the payout ratio under control, which is less than the 35% EPS growth achieved over the last 5 years.お知らせ • Mar 08Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024The Board of Directors of Extendicare Inc. declared a cash dividend of CAD 0.04 per share for the month of March 2024, which is payable on April 15, 2024, to shareholders of record at the close of business on March 29, 2024.Reported Earnings • Mar 08Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)Full year 2023 results: EPS: CA$0.40 (up from CA$0.051 loss in FY 2022). Revenue: CA$1.30b (up 6.8% from FY 2022). Net income: CA$34.0m (up CA$38.5m from FY 2022). Profit margin: 2.6% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 1.1% p.a. on average during the next 2 years, while revenues in the Healthcare industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.Upcoming Dividend • Feb 21Upcoming dividend of CA$0.04 per shareEligible shareholders must have bought the stock before 28 February 2024. Payment date: 15 March 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.1%. Within top quartile of German dividend payers (5.2%). Higher than average of industry peers (3.1%).Declared Dividend • Feb 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 28th February 2024 Payment date: 15th March 2024 Dividend yield will be 7.2%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (233% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 158% to bring the payout ratio under control. However, EPS has declined by 7.3% over the last 5 years so the company would need to reverse this trend.お知らせ • Feb 16Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2024, which is payable on March 15, 2024 to shareholders of record at the close of business on February 29, 2024. This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada).Upcoming Dividend • Jan 23Upcoming dividend of CA$0.04 per share at 6.7% yieldEligible shareholders must have bought the stock before 30 January 2024. Payment date: 15 February 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.7%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.3%).お知らせ • Jan 20Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024Extendicare Inc. announced that they will report Q4, 2023 results on Mar 07, 2024お知らせ • Dec 16Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the Common Share) for the month of December 2023, which is payable on January 15, 2024 to shareholders of record at the close of business on December 29, 2023.Recent Insider Transactions • Dec 03Independent Director recently bought €67k worth of stockOn the 30th of November, Sandra Hanington bought around 14k shares on-market at roughly €4.70 per share. This transaction amounted to 56% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €579k more in shares than they have sold in the last 12 months.Upcoming Dividend • Nov 22Upcoming dividend of CA$0.04 per share at 7.4% yieldEligible shareholders must have bought the stock before 29 November 2023. Payment date: 15 December 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.4%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.2%).Reported Earnings • Nov 12Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.14 (up from CA$0.049 loss in 3Q 2022). Revenue: CA$322.5m (up 4.4% from 3Q 2022). Net income: CA$11.8m (up CA$16.2m from 3Q 2022). Profit margin: 3.7% (up from net loss in 3Q 2022). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.0% decline forecast for the Healthcare industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.お知らせ • Nov 11Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of November 2023, which is payable on December 15, 2023, to shareholders of record at the close of business on November 30, 2023.Upcoming Dividend • Oct 23Upcoming dividend of CA$0.04 per share at 7.9% yieldEligible shareholders must have bought the stock before 30 October 2023. Payment date: 15 November 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.9%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.5%).お知らせ • Oct 17Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of October 2023, which is payable on November 15, 2023 to shareholders of record at the close of business on October 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Oct 07Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023Extendicare Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 09, 2023Upcoming Dividend • Sep 21Upcoming dividend of CA$0.04 per share at 7.8% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 16 October 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.8%. Within top quartile of German dividend payers (4.8%). Higher than average of industry peers (2.9%).お知らせ • Sep 16Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of September 2023, which is payable on October 16, 2023 to shareholders of record at the close of business on September 29, 2023.Upcoming Dividend • Aug 23Upcoming dividend of CA$0.04 per share at 7.4% yieldEligible shareholders must have bought the stock before 30 August 2023. Payment date: 15 September 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.4%. Within top quartile of German dividend payers (4.9%). Higher than average of industry peers (3.0%).New Risk • Aug 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.1% Last year net profit margin: 0.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.2% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Dividend per share is over 14x earnings per share. Paying a dividend despite having no free cash flows. Earnings have declined by 14% per year over the past 5 years. High level of non-cash earnings (32% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (0.1% net profit margin).お知らせ • Aug 11Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of August 2023, which is payable on September 15, 2023, to shareholders of record at the close of business on August 31, 2023. This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada).Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)Second quarter 2023 results: EPS: CA$0.02 (down from CA$0.039 in 2Q 2022). Revenue: CA$307.5m (up 3.7% from 2Q 2022). Net income: CA$1.95m (down 44% from 2Q 2022). Profit margin: 0.6% (down from 1.2% in 2Q 2022). Revenue is forecast to grow 5.1% p.a. on average during the next 2 years, compared to a 4.0% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.お知らせ • Aug 03Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.Extendicare Inc. (TSX:EXE) entered into an agreement to acquire a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. on March 1, 2022. Extendicare will acquire a 15% managed interest in 18 “class A” long-term care homes located in Ontario and six homes in Manitoba. The remaining 85% interest will continue to be owned by an affiliate of Axium. Relatedly, on closing of the Acquisition, Extendicare will enter into management contracts with Revera to manage all of Revera’s other long-term care homes, which comprise 31 “class C” homes located in Ontario and one personal care home located in Manitoba. Extendicare will also enter into development arrangement agreements with Revera in respect of the potential redevelopment of those managed “class C” homes in Ontario into new homes. The aggregate cash consideration for the Transactions is approximately CAD 36.0 million plus the assumption of approximately CAD 34.0 million in debt, subject to customary adjustments. Certain of the associated debt will be refinanced or repaid on or before closing, resulting in changes in the allocation between cash consideration and debt assumption. The purchase price is expected to be funded from cash on hand. Closing of the Axium Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, and is not conditional on financing or due diligence. As of May 4, 2023, the transaction is expected to close by the end of Q3 2023. BMO Capital Markets is acting as financial advisor to Extendicare and Simon Knowling, Graham Rawlinson, Susan Nickerson, Craig Maurice and Nina Mansoori of Torys LLP is acting as legal advisor to Extendicare in connection with the Transactions. Stikeman Elliott LLP is acting as legal advisor to Axium in connection with the Transactions. Stormont Partners Advisory is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Revera Transactions.Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc. on August 1, 2022.お知らせ • Jul 18Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of July 2023, which is payable on August 15, 2023 to shareholders of record at the close of business on July 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).お知らせ • Jul 07Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023Extendicare Inc. announced that they will report Q2, 2023 results After-Market on Aug 10, 2023お知らせ • Jun 16Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (The Common Share) for the month of June 2023, which Is Payable on July 17, 2023 to shareholders of record At the close of business on June 30, 2023.Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. Independent Director Brent M. Houlden was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.Recent Insider Transactions • May 31Independent Director recently bought €74k worth of stockOn the 26th of May, Brent M. Houlden bought around 15k shares on-market at roughly €4.92 per share. This trade did not impact their existing holding. In the last 3 months, there was an even bigger purchase from another insider worth €140k. Insiders have collectively bought €498k more in shares than they have sold in the last 12 months.Upcoming Dividend • May 23Upcoming dividend of CA$0.04 per share at 6.6% yieldEligible shareholders must have bought the stock before 30 May 2023. Payment date: 15 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.6%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (3.1%).Recent Insider Transactions • May 12Senior Vice President of ParaMed & CTO recently bought €140k worth of stockOn the 9th of May, Steve Paraskevopoulos bought around 30k shares on-market at roughly €4.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €424k more in shares than they have sold in the last 12 months.Reported Earnings • May 07First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022)First quarter 2023 results: EPS: CA$0.14 (up from CA$0.045 in 1Q 2022). Revenue: CA$324.7m (up 6.2% from 1Q 2022). Net income: CA$11.6m (up 186% from 1Q 2022). Profit margin: 3.6% (up from 1.3% in 1Q 2022). Revenue is forecast to grow 1.7% p.a. on average during the next 2 years, compared to a 3.9% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Recent Insider Transactions • Apr 03CEO, President & Director recently bought €128k worth of stockOn the 28th of March, Michael Guerriere bought around 30k shares on-market at roughly €4.26 per share. This transaction amounted to 18% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months.Upcoming Dividend • Mar 23Upcoming dividend of CA$0.04 per share at 7.9% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 17 April 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 7.9%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (3.4%).Reported Earnings • Mar 03Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021)Full year 2022 results: CA$0.051 loss per share (down from CA$0.10 profit in FY 2021). Revenue: CA$1.22b (flat on FY 2021). Net loss: CA$4.51m (down 150% from profit in FY 2021). Revenue is forecast to grow 1.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.株主還元5XEDE HealthcareDE 市場7D-5.6%1.7%0.7%1Y150.3%6.4%3.7%株主還元を見る業界別リターン: 5XE過去 1 年間で6.4 % の収益を上げたGerman Healthcare業界を上回りました。リターン対市場: 5XE過去 1 年間で3.7 % の収益を上げたGerman市場を上回りました。価格変動Is 5XE's price volatile compared to industry and market?5XE volatility5XE Average Weekly Movement5.5%Healthcare Industry Average Movement5.6%Market Average Movement5.3%10% most volatile stocks in DE Market12.8%10% least volatile stocks in DE Market2.7%安定した株価: 5XE 、 German市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 5XEの 週次ボラティリティ ( 5% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト1968n/aMichael Guerrierewww.extendicare.comエクステンディケア社は、その子会社を通じて、カナダで高齢者向けのケアとサービスを提供している。同社は、長期介護サービス、看護ケア、作業療法、理学療法、言語療法、日常生活支援などの在宅医療サービス、管理、コンサルティング、その他のサービスを第三者に提供している。Extendicare、ParaMed、Extendicare Assist、SGP Purchasing Partner Networkのブランドで事業を展開している。同社は1968年に法人化され、カナダのマーカムに本社を置いている。もっと見るExtendicare Inc. 基礎のまとめExtendicare の収益と売上を時価総額と比較するとどうか。5XE 基礎統計学時価総額€1.92b収益（TTM）€75.38m売上高(TTM)€1.23b25.5xPER（株価収益率1.6xP/Sレシオ5XE は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計5XE 損益計算書（TTM）収益CA$1.98b売上原価CA$1.69b売上総利益CA$286.85mその他の費用CA$165.57m収益CA$121.28m直近の収益報告Jun 30, 2026次回決算日該当なし一株当たり利益（EPS）1.28グロス・マージン14.50%純利益率6.13%有利子負債／自己資本比率151.5%5XE の長期的なパフォーマンスは？過去の実績と比較を見る配当金1.6%現在の配当利回り38%配当性向5XE 配当は確実ですか？5XE 配当履歴とベンチマークを見る5XE 、いつまでに購入すれば配当金を受け取れますか？Extendicare 配当日配当落ち日Jul 31 2026配当支払日Aug 17 2026配当落ちまでの日数12 days配当支払日までの日数5 days5XE 配当は確実ですか？5XE 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/10 17:05終値2026/08/10 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Extendicare Inc. 6 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。13 アナリスト機関Kyle McPheeATB CormarkTom CallaghanBMO Capital Markets Equity ResearchTania Armstrong-WhitworthCanaccord Genuity10 その他のアナリストを表示
New Risk • Aug 07New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 136% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (136% net debt to equity). Significant insider selling over the past 3 months (€4.2m sold).
Reported Earnings • Aug 07Second quarter 2026 earnings released: EPS: CA$0.32 (vs CA$0.38 in 2Q 2025)Second quarter 2026 results: EPS: CA$0.32 (down from CA$0.38 in 2Q 2025). Revenue: CA$611.0m (up 59% from 2Q 2025). Net income: CA$30.9m (down 3.4% from 2Q 2025). Profit margin: 5.0% (down from 8.3% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 61% per year, which means it is tracking significantly ahead of earnings growth.
Declared Dividend • Jul 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 31st July 2026 Payment date: 17th August 2026 Dividend yield will be 1.4%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jul 16Extendicare Announces July 2026 Dividend, Payable on August 17, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
お知らせ • Jul 07Extendicare Inc. to Report Q2, 2026 Results on Aug 06, 2026Extendicare Inc. announced that they will report Q2, 2026 results After-Market on Aug 06, 2026
Declared Dividend • Jun 25Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.6%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
New Risk • Aug 07New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 136% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (136% net debt to equity). Significant insider selling over the past 3 months (€4.2m sold).
Reported Earnings • Aug 07Second quarter 2026 earnings released: EPS: CA$0.32 (vs CA$0.38 in 2Q 2025)Second quarter 2026 results: EPS: CA$0.32 (down from CA$0.38 in 2Q 2025). Revenue: CA$611.0m (up 59% from 2Q 2025). Net income: CA$30.9m (down 3.4% from 2Q 2025). Profit margin: 5.0% (down from 8.3% in 2Q 2025). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has increased by 61% per year, which means it is tracking significantly ahead of earnings growth.
Declared Dividend • Jul 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 31st July 2026 Payment date: 17th August 2026 Dividend yield will be 1.4%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jul 16Extendicare Announces July 2026 Dividend, Payable on August 17, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of July 2026, which is payable on August 17, 2026 to shareholders of record at the close of business on July 31, 2026. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
お知らせ • Jul 07Extendicare Inc. to Report Q2, 2026 Results on Aug 06, 2026Extendicare Inc. announced that they will report Q2, 2026 results After-Market on Aug 06, 2026
Declared Dividend • Jun 25Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 30th June 2026 Payment date: 15th July 2026 Dividend yield will be 1.6%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Jun 15Extendicare Inc. Declares Cash Dividend for the Month of June 2026, Payable on July 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of June 2026, which is payable on July 15, 2026 to shareholders of record at the close of business on June 30, 2026.
Declared Dividend • May 20Dividend of CA$0.044 announcedShareholders will receive a dividend of CA$0.044. Ex-date: 29th May 2026 Payment date: 15th June 2026 Dividend yield will be 1.6%, which is lower than the industry average of 3.3%. Sustainability & Growth Dividend is covered by both earnings (36% earnings payout ratio) and cash flows (55% cash payout ratio). The dividend has increased over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability. Earnings per share has grown by 19% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • May 09Extendicare Inc. Declares Cash Dividend for the Month of May 2026, Payable on June 15, 2026The Board of Directors of Extendicare declared a cash dividend of CAD 0.0441 per share for the month of May 2026, which is payable on June 15, 2026, to shareholders of record at the close of business on May 29, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Apr 17+ 1 more updateExtendicare Inc. Announces April 2026 Cash Dividend, Payable on May 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.0441 per common share of the Company for the month of April 2026, which is payable on May 15, 2026 to shareholders of record at the close of business on April 30, 2026.
お知らせ • Apr 06Extendicare Inc. to Report Q1, 2026 Results on May 07, 2026Extendicare Inc. announced that they will report Q1, 2026 results After-Market on May 07, 2026
お知らせ • Mar 19Extendicare Inc. Announces Alan Torrie, Chair of the Board, and Donna Kingelin, Board Member, Will Not Stand for Re-ElectionExtendicare Inc. announced that current Board members Alan Torrie, Chair of the Board, and Donna Kingelin will not stand for re-election at the Meeting following over 10 years of service. Alan’s leadership and vision during his nine years as Chair enabled the transition of Extendicare from its real estate focus to a new business model focused on health services. Donna chaired the HR Committee and subsequently the Quality and Risk Committee during her tenure, building pivotal capabilities that are core to the Company’s health services mandate.
お知らせ • Feb 27Extendicare Inc. Increases Cash Dividend for the Month of March 2026Extendicare Inc. is increasing its monthly dividend by 5% to 4.41 cents per share, effective with the dividend to be declared in March 2026. Building on the 5% increase last year, the increase reflects the sustained operating performance throughout 2025 and sound capital structure. Continued strong performance would give the Company the opportunity to consider further dividend increases.
お知らせ • Feb 17Extendicare Inc. Declares Cash Dividend for the Month of February 2026, Payable on March 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of February 2026, which is payable on March 16, 2026 to shareholders of record at the close of business on February 27, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Jan 27Extendicare Inc., Annual General Meeting, Apr 16, 2026Extendicare Inc., Annual General Meeting, Apr 16, 2026.
お知らせ • Jan 16Extendicare Inc. to Report Q4, 2025 Results on Feb 26, 2026Extendicare Inc. announced that they will report Q4, 2025 results at 4:00 PM, US Eastern Standard Time on Feb 26, 2026
お知らせ • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2026, Payable on February 16, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of January 2026, which is payable on February 16, 2026 to shareholders of record at the close of business on January 30, 2026. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Dec 13Extendicare Inc. Declares Cash Dividend on Common Share for the Month of December 2025, Payable on January 15, 2026Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of December 2025, which is payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Nov 20Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million.Extendicare Inc. (TSX:EXE) entered into a definitive agreement to acquire CBI Home Health from CBI Health Group Inc. for $570 million on November 19, 2025. The transaction will be financed through cash on hand, proceeds from the Offering of $192 million and senior debt of $264.5 million. For the period ending July 31, 2025, CBI Home Health reported total revenue of $478 million and EBITDA of $62 million. The transaction is subject to customary closing conditions, including receipt of consents from third parties, including Ontario Health atHome and Assisted Living Alberta, and regulatory approval pursuant to the Competition Act. The transaction is expected to close in the first quarter of 2026. The transaction will be immediately accretive to earnings per share. CIBC Capital Markets, Research Division acted as financial advisor for Extendicare Inc. Torys LLP acted as legal advisor for Extendicare Inc. Houlihan Lokey, Inc. acted as financial advisor for CBI Home Health. TD Securities, Inc. acted as financial advisor for CBI Home Health. Stikeman Elliott LLP acted as legal advisor for CBI Home Health.
お知らせ • Nov 13Extendicare Inc. announces Monthly dividend, payable on December 15, 2025Extendicare Inc. announced Monthly dividend of CAD 0.0420 per share payable on December 15, 2025, ex-date on November 28, 2025 and record date on November 28, 2025.
お知らせ • Oct 15Extendicare Inc. Declares Cash Dividend on Common Share for the Month of October 2025, Payable on November 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of October 2025, which is payable on November 17, 2025 to shareholders of record at the close of business on October 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Oct 07Extendicare Inc. to Report Q3, 2025 Results on Nov 11, 2025Extendicare Inc. announced that they will report Q3, 2025 results After-Market on Nov 11, 2025
お知らせ • Sep 15Extendicare Inc. Announces September 2025 Dividend, Payable on October 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of September 2025, which is payable on October 15, 2025 to shareholders of record at the close of business on September 30, 2025.
お知らせ • Aug 07Extendicare Inc. Declares Cash Dividend for the Month of August 2025, Payable on September 15, 2025The Board of Directors of Extendicare declared a cash dividend of $0.042 per share for the month of August 2025, which is payable on September 15, 2025, to shareholders of record at the close of business on August 29, 2025.
お知らせ • Jul 15Extendicare Inc. Declares Cash Dividend for the Month of July 2025, Payable on August 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of July 2025, which is payable on August 15, 2025 to shareholders of record at the close of business on July 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Jul 07Extendicare Inc. to Report Q2, 2025 Results on Aug 06, 2025Extendicare Inc. announced that they will report Q2, 2025 results After-Market on Aug 06, 2025
お知らせ • Jun 18Extendicare Inc. Declares Cash Dividend for the Month of June 2025, Payable on July 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of June 2025, which is payable on July 15, 2025 to shareholders of record at the close of business on June 30, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Jun 03Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc.Extendicare Inc. (TSX:EXE) has entered into an agreement to acquire Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. for CAD 60.3 million on November 28, 2024. As for the consideration, it was approximately $60.3 million, consisting of $40.2 million in cash and the assumption of $20.1 million in certain liabilities, including government funding reimbursement obligations and committed capital maintenance project obligations, excluding transaction costs. The purchase price was funded from cash on hand.The purchase price is expected to be funded from cash on hand and existing senior secured credit facilities. Closing of the Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, Ontario Retirement Home Regulatory Authority, and Manitoba Health and Winnipeg Regional Health Authority, and is not conditional on financing or due diligence. The Transaction is expected to close in the second quarter. Torys LLP is acting as legal advisor to Extendicare in connection with the Transaction. Stormont Partners is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Transaction. Extendicare Inc. (TSX:EXE) completed the acquisition of Nine Long-Term Care Homes located Ontario and Manitoba from Revera Inc. on June 1, 2025.
お知らせ • May 07Extendicare Inc. Declares Cash Dividend for the Month of May 2025, Payable on June 16, 2025The board of directors of Extendicare Inc. declared a cash dividend of CAD 0.042 per share for the month of May 2025, which is payable on June 16, 2025, to shareholders of record at the close of business on May 30, 2025.
お知らせ • Apr 16Extendicare Inc Declares Cash Dividend for the Month of April 2025, Payable on May 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company for the month of April 2025, which is payable on May 15, 2025 to shareholders of record at the close of business on April 30, 2025. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
お知らせ • Apr 03Extendicare Inc. to Report Q1, 2025 Results on May 06, 2025Extendicare Inc. announced that they will report Q1, 2025 results After-Market on May 06, 2025
お知らせ • Mar 18Extendicare Inc. Declares a Cash Dividend for the Month of March 2025, Payable on April 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.042 per common share of the Company (the “Common Share”) for the month of March 2025, which is payable on April 15, 2025 to shareholders of record at the close of business on March 31, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Mar 17Extendicare Inc., Annual General Meeting, May 27, 2025Extendicare Inc., Annual General Meeting, May 27, 2025. Location: ontario, toronto Canada
お知らせ • Feb 28+ 1 more updateExtendicare Inc. Announces Dividend IncreaseExtendicare Inc. announced improved performance and growth in all three business segments has resulted in the dividend payout ratio dropping below 50%. Accordingly, the Company will increase its dividend by 5.0% to 4.2 cents per month effective with the dividend to be declared in March 2025.
お知らせ • Feb 14Extendicare Inc. Announces Cash Dividend for the Month of February 2025, Payable on March 17, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2025, which is payable on March 17, 2025 to shareholders of record at the close of business on February 28, 2025. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Jan 15Extendicare Inc. Declares Cash Dividend for the Month of January 2025, Payable on February 14, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (the common share) for the month of January 2025, which is payable on February 14, 2025 to shareholders of record at the close of business on January 31, 2025.
お知らせ • Jan 13Extendicare Inc. to Report Q4, 2024 Results on Feb 27, 2025Extendicare Inc. announced that they will report Q4, 2024 results After-Market on Feb 27, 2025
お知らせ • Dec 13Extendicare Announces December 2024 Dividend, Payable on January 15, 2025Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of December 2024, which is payable on January 15, 2025 to shareholders of record at the close of business on December 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Reported Earnings • Nov 14Third quarter 2024 earnings released: EPS: CA$0.20 (vs CA$0.14 in 3Q 2023)Third quarter 2024 results: EPS: CA$0.20 (up from CA$0.14 in 3Q 2023). Revenue: CA$359.1m (up 11% from 3Q 2023). Net income: CA$16.3m (up 38% from 3Q 2023). Profit margin: 4.5% (up from 3.7% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.5% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth.
お知らせ • Nov 13Extendicare Inc. Declares Cash Dividend, Payable on December 16, 2024The Board of Directors of Extendicare Inc. declared a cash dividend of $0.04 per share for the month of November 2024, which is payable on December 16, 2024, to shareholders of record at the close of business on November 29, 2024.
Declared Dividend • Oct 18Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st October 2024 Payment date: 15th November 2024 Dividend yield will be 5.5%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Oct 15Extendicare Inc. Declares Cash Dividend for the Month of October 2024, Payable on November 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of October 2024, which is payable on November 15, 2024 to shareholders of record at the close of business on October 31, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Oct 04Extendicare Inc. to Report Q3, 2024 Results on Nov 12, 2024Extendicare Inc. announced that they will report Q3, 2024 results After-Market on Nov 12, 2024
Declared Dividend • Sep 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 27th September 2024 Payment date: 15th October 2024 Dividend yield will be 5.7%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
お知らせ • Sep 16Extendicare Inc. Announces Cash Dividend for the Month of September 2024, Payable on October 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of September 2024, which is payable on October 15, 2024 to shareholders of record at the close of business on September 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
Declared Dividend • Aug 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 30th August 2024 Payment date: 16th September 2024 Dividend yield will be 6.4%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is covered by earnings (68% earnings payout ratio) but not covered by cash flows (149% cash payout ratio). The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. Earnings per share has grown by 78% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Reported Earnings • Aug 13Second quarter 2024 earnings released: EPS: CA$0.30 (vs CA$0.023 in 2Q 2023)Second quarter 2024 results: EPS: CA$0.30 (up from CA$0.023 in 2Q 2023). Revenue: CA$348.5m (up 13% from 2Q 2023). Net income: CA$25.9m (up CA$23.9m from 2Q 2023). Profit margin: 7.4% (up from 0.6% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.3% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has increased by 24% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings.
Declared Dividend • Jul 22Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st July 2024 Payment date: 15th August 2024 Dividend yield will be 6.9%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.
お知らせ • Jul 15Extendicare Inc. Announces July 2024 Cash Dividend, Payable on August 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of July 2024, which is payable on August 15, 2024 to shareholders of record at the close of business on July 31, 2024.
お知らせ • Jul 06Extendicare Inc. to Report Q2, 2024 Results on Aug 12, 2024Extendicare Inc. announced that they will report Q2, 2024 results After-Market on Aug 12, 2024
Recent Insider Transactions • Jul 05Senior Vice President of ParaMed & CTO recently bought €67k worth of stockOn the 28th of June, Steve Paraskevopoulos bought around 14k shares on-market at roughly €4.93 per share. This transaction amounted to 45% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €135k more in shares than they have sold in the last 12 months.
Declared Dividend • Jun 24Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 28th June 2024 Payment date: 15th July 2024 Dividend yield will be 7.0%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (114% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.
お知らせ • Jun 18Extendicare Inc. Declares Cash Dividend for the Month of June 2024, Payable on July 15, 2024Extendicare Inc. announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common Share”) for the month of June 2024, which is payable on July 15, 2024 to shareholders of record at the close of business on June 28, 2024.
お知らせ • May 24Extendicare Inc. Announces Alan Hibben Not Been Re-Elected as A DirectorExtendicare Inc. at the annual meeting of shareholders held on May 23, 2024 announced that Alan Hibben did not receive a majority of votes in favour at the Meeting and thus has not been re-elected as a director of Extendicare and resigned as such effective at the end of the Meeting.
Declared Dividend • May 20Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 31st May 2024 Payment date: 17th June 2024 Dividend yield will be 7.1%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (115% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 27% to bring the payout ratio under control, which is less than the 47% EPS growth achieved over the last 5 years.
Reported Earnings • May 17First quarter 2024 earnings released: EPS: CA$0.16 (vs CA$0.14 in 1Q 2023)First quarter 2024 results: EPS: CA$0.16 (up from CA$0.14 in 1Q 2023). Revenue: CA$367.1m (up 13% from 1Q 2023). Net income: CA$13.1m (up 13% from 1Q 2023). Profit margin: 3.6% (in line with 1Q 2023). Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 3.8% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
お知らせ • May 17Extendicare Inc. Declares Cash Dividend for the Month of May 2024, Payable on June 17, 2024The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of May 2024, which is payable on June 17, 2024, to shareholders of record at the close of business on May 31, 2024.
Upcoming Dividend • Apr 25Upcoming dividend of CA$0.04 per shareEligible shareholders must have bought the stock before 29 April 2024. Payment date: 15 May 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.6%. Within top quartile of German dividend payers (4.8%). Higher than average of industry peers (2.9%).
Declared Dividend • Apr 23Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 29th April 2024 Payment date: 15th May 2024 Dividend yield will be 7.1%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (120% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has not increased over the past 10 years but has been stable with no material reductions to payments, indicating a long track record of dividend stability. The company's earnings per share (EPS) would need to grow by 33% to bring the payout ratio under control, which is less than the 35% EPS growth achieved over the last 5 years.
お知らせ • Apr 21Extendicare Inc., Annual General Meeting, May 23, 2024Extendicare Inc., Annual General Meeting, May 23, 2024, at 10:30 Eastern Daylight. Location: TMX Market Centre, 120 Adelaide Street West, Toronto Ontario Canada Agenda: To consider to receive the consolidated financial statements of the Company for the year ended December 31, 2023 and the report of the auditors thereon; to appoint the auditors of the Company and authorize the directors to fix the auditors remuneration; to elect the directors of the Company; to approve an advisory (non-binding) resolution to accept the approach of the Company to executive compensation disclosed in the Information Circular; and to discuss other matters.
お知らせ • Apr 15Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of April 2024, which is payable on May 15, 2024 to shareholders of record at the close of business on April 30, 2024. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Apr 05Extendicare Inc. to Report Q1, 2024 Results on May 15, 2024Extendicare Inc. announced that they will report Q1, 2024 results After-Market on May 15, 2024
Upcoming Dividend • Mar 20Upcoming dividend of CA$0.04 per shareEligible shareholders must have bought the stock before 27 March 2024. Payment date: 15 April 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.2%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.1%).
Declared Dividend • Mar 18Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 27th March 2024 Payment date: 15th April 2024 Dividend yield will be 7.0%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (120% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 33% to bring the payout ratio under control, which is less than the 35% EPS growth achieved over the last 5 years.
お知らせ • Mar 08Extendicare Inc. Declares Cash Dividend for the Month of March 2024, Payable on April 15, 2024The Board of Directors of Extendicare Inc. declared a cash dividend of CAD 0.04 per share for the month of March 2024, which is payable on April 15, 2024, to shareholders of record at the close of business on March 29, 2024.
Reported Earnings • Mar 08Full year 2023 earnings released: EPS: CA$0.40 (vs CA$0.051 loss in FY 2022)Full year 2023 results: EPS: CA$0.40 (up from CA$0.051 loss in FY 2022). Revenue: CA$1.30b (up 6.8% from FY 2022). Net income: CA$34.0m (up CA$38.5m from FY 2022). Profit margin: 2.6% (up from net loss in FY 2022). The move to profitability was driven by higher revenue. Revenue is forecast to grow 1.1% p.a. on average during the next 2 years, while revenues in the Healthcare industry in Germany are expected to remain flat. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • Feb 21Upcoming dividend of CA$0.04 per shareEligible shareholders must have bought the stock before 28 February 2024. Payment date: 15 March 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.1%. Within top quartile of German dividend payers (5.2%). Higher than average of industry peers (3.1%).
Declared Dividend • Feb 19Dividend of CA$0.04 announcedShareholders will receive a dividend of CA$0.04. Ex-date: 28th February 2024 Payment date: 15th March 2024 Dividend yield will be 7.2%, which is higher than the industry average of 3.3%. Sustainability & Growth Dividend is not covered by earnings (233% earnings payout ratio) and the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to grow by 158% to bring the payout ratio under control. However, EPS has declined by 7.3% over the last 5 years so the company would need to reverse this trend.
お知らせ • Feb 16Extendicare Inc. Declares Cash Dividend for the Month of February 2024, Payable on March 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of February 2024, which is payable on March 15, 2024 to shareholders of record at the close of business on February 29, 2024. This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada).
Upcoming Dividend • Jan 23Upcoming dividend of CA$0.04 per share at 6.7% yieldEligible shareholders must have bought the stock before 30 January 2024. Payment date: 15 February 2024. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.7%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.3%).
お知らせ • Jan 20Extendicare Inc. to Report Q4, 2023 Results on Mar 07, 2024Extendicare Inc. announced that they will report Q4, 2023 results on Mar 07, 2024
お知らせ • Dec 16Extendicare Inc. Declares Cash Dividend for the Month of December 2023, Payable on January 15, 2024Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the Common Share) for the month of December 2023, which is payable on January 15, 2024 to shareholders of record at the close of business on December 29, 2023.
Recent Insider Transactions • Dec 03Independent Director recently bought €67k worth of stockOn the 30th of November, Sandra Hanington bought around 14k shares on-market at roughly €4.70 per share. This transaction amounted to 56% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €579k more in shares than they have sold in the last 12 months.
Upcoming Dividend • Nov 22Upcoming dividend of CA$0.04 per share at 7.4% yieldEligible shareholders must have bought the stock before 29 November 2023. Payment date: 15 December 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.4%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.2%).
Reported Earnings • Nov 12Third quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.049 loss in 3Q 2022)Third quarter 2023 results: EPS: CA$0.14 (up from CA$0.049 loss in 3Q 2022). Revenue: CA$322.5m (up 4.4% from 3Q 2022). Net income: CA$11.8m (up CA$16.2m from 3Q 2022). Profit margin: 3.7% (up from net loss in 3Q 2022). Revenue is forecast to grow 2.6% p.a. on average during the next 3 years, compared to a 1.0% decline forecast for the Healthcare industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance.
お知らせ • Nov 11Extendicare Inc. Declares Cash Dividend for the Month of November 2023, Payable on December 15, 2023The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of November 2023, which is payable on December 15, 2023, to shareholders of record at the close of business on November 30, 2023.
Upcoming Dividend • Oct 23Upcoming dividend of CA$0.04 per share at 7.9% yieldEligible shareholders must have bought the stock before 30 October 2023. Payment date: 15 November 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.9%. Within top quartile of German dividend payers (5.0%). Higher than average of industry peers (3.5%).
お知らせ • Oct 17Extendicare Inc. Declares Cash Dividend for the Month of October 2023, Payable on November 15, 2023Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of October 2023, which is payable on November 15, 2023 to shareholders of record at the close of business on October 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Oct 07Extendicare Inc. to Report Q3, 2023 Results on Nov 09, 2023Extendicare Inc. announced that they will report Q3, 2023 results at 4:00 PM, US Eastern Standard Time on Nov 09, 2023
Upcoming Dividend • Sep 21Upcoming dividend of CA$0.04 per share at 7.8% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 16 October 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.8%. Within top quartile of German dividend payers (4.8%). Higher than average of industry peers (2.9%).
お知らせ • Sep 16Extendicare Inc. Announces Cash Dividend for the September 2023, Payable on October 16, 2023Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company for the month of September 2023, which is payable on October 16, 2023 to shareholders of record at the close of business on September 29, 2023.
Upcoming Dividend • Aug 23Upcoming dividend of CA$0.04 per share at 7.4% yieldEligible shareholders must have bought the stock before 30 August 2023. Payment date: 15 September 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 7.4%. Within top quartile of German dividend payers (4.9%). Higher than average of industry peers (3.0%).
New Risk • Aug 11New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 0.1% Last year net profit margin: 0.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (6.2% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Dividend per share is over 14x earnings per share. Paying a dividend despite having no free cash flows. Earnings have declined by 14% per year over the past 5 years. High level of non-cash earnings (32% accrual ratio). Minor Risk Profit margins are more than 30% lower than last year (0.1% net profit margin).
お知らせ • Aug 11Extendicare Inc. Declares Cash Dividend for the Month of August 2023, Payable on September 15, 2023The Board of Directors of Extendicare declared a cash dividend of $0.04 per share for the month of August 2023, which is payable on September 15, 2023, to shareholders of record at the close of business on August 31, 2023. This dividend is designated as an eligible dividend within the meaning of the Income Tax Act (Canada).
Reported Earnings • Aug 11Second quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.039 in 2Q 2022)Second quarter 2023 results: EPS: CA$0.02 (down from CA$0.039 in 2Q 2022). Revenue: CA$307.5m (up 3.7% from 2Q 2022). Net income: CA$1.95m (down 44% from 2Q 2022). Profit margin: 0.6% (down from 1.2% in 2Q 2022). Revenue is forecast to grow 5.1% p.a. on average during the next 2 years, compared to a 4.0% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance.
お知らせ • Aug 03Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc.Extendicare Inc. (TSX:EXE) entered into an agreement to acquire a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. on March 1, 2022. Extendicare will acquire a 15% managed interest in 18 “class A” long-term care homes located in Ontario and six homes in Manitoba. The remaining 85% interest will continue to be owned by an affiliate of Axium. Relatedly, on closing of the Acquisition, Extendicare will enter into management contracts with Revera to manage all of Revera’s other long-term care homes, which comprise 31 “class C” homes located in Ontario and one personal care home located in Manitoba. Extendicare will also enter into development arrangement agreements with Revera in respect of the potential redevelopment of those managed “class C” homes in Ontario into new homes. The aggregate cash consideration for the Transactions is approximately CAD 36.0 million plus the assumption of approximately CAD 34.0 million in debt, subject to customary adjustments. Certain of the associated debt will be refinanced or repaid on or before closing, resulting in changes in the allocation between cash consideration and debt assumption. The purchase price is expected to be funded from cash on hand. Closing of the Axium Transaction is subject to customary closing conditions, including receipt of regulatory approvals from the Ontario Ministry of Long-Term Care, and is not conditional on financing or due diligence. As of May 4, 2023, the transaction is expected to close by the end of Q3 2023. BMO Capital Markets is acting as financial advisor to Extendicare and Simon Knowling, Graham Rawlinson, Susan Nickerson, Craig Maurice and Nina Mansoori of Torys LLP is acting as legal advisor to Extendicare in connection with the Transactions. Stikeman Elliott LLP is acting as legal advisor to Axium in connection with the Transactions. Stormont Partners Advisory is acting as financial advisor to Revera and Goodmans LLP is acting as legal advisor to Revera in connection with the Revera Transactions.Extendicare Inc. (TSX:EXE) completed the acquisition of a 15 percent stake in a Portfolio of 24 Long Term Care Homes from Revera Inc. and Axium Infrastructure Inc. on August 1, 2022.
お知らせ • Jul 18Extendicare Inc. Declares Cash Dividend for the Month of July 2023, Payable on August 15, 2023Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the Company (the “Common Share”) for the month of July 2023, which is payable on August 15, 2023 to shareholders of record at the close of business on July 31, 2023. This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act (Canada).
お知らせ • Jul 07Extendicare Inc. to Report Q2, 2023 Results on Aug 10, 2023Extendicare Inc. announced that they will report Q2, 2023 results After-Market on Aug 10, 2023
お知らせ • Jun 16Extendicare Inc. Declares Cash Dividend for the Month of June 2023, Payable on July 17, 2023Extendicare Inc. announced that it has declared a cash dividend of CAD 0.04 per common share of the company (The Common Share) for the month of June 2023, which Is Payable on July 17, 2023 to shareholders of record At the close of business on June 30, 2023.
Board Change • Jun 01Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 11 experienced directors. 1 highly experienced director. Independent Director Brent M. Houlden was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment.
Recent Insider Transactions • May 31Independent Director recently bought €74k worth of stockOn the 26th of May, Brent M. Houlden bought around 15k shares on-market at roughly €4.92 per share. This trade did not impact their existing holding. In the last 3 months, there was an even bigger purchase from another insider worth €140k. Insiders have collectively bought €498k more in shares than they have sold in the last 12 months.
Upcoming Dividend • May 23Upcoming dividend of CA$0.04 per share at 6.6% yieldEligible shareholders must have bought the stock before 30 May 2023. Payment date: 15 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 6.6%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (3.1%).
Recent Insider Transactions • May 12Senior Vice President of ParaMed & CTO recently bought €140k worth of stockOn the 9th of May, Steve Paraskevopoulos bought around 30k shares on-market at roughly €4.66 per share. This trade did not impact their existing holding. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €424k more in shares than they have sold in the last 12 months.
Reported Earnings • May 07First quarter 2023 earnings released: EPS: CA$0.14 (vs CA$0.045 in 1Q 2022)First quarter 2023 results: EPS: CA$0.14 (up from CA$0.045 in 1Q 2022). Revenue: CA$324.7m (up 6.2% from 1Q 2022). Net income: CA$11.6m (up 186% from 1Q 2022). Profit margin: 3.6% (up from 1.3% in 1Q 2022). Revenue is forecast to grow 1.7% p.a. on average during the next 2 years, compared to a 3.9% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 53% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Recent Insider Transactions • Apr 03CEO, President & Director recently bought €128k worth of stockOn the 28th of March, Michael Guerriere bought around 30k shares on-market at roughly €4.26 per share. This transaction amounted to 18% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Michael's only on-market trade for the last 12 months.
Upcoming Dividend • Mar 23Upcoming dividend of CA$0.04 per share at 7.9% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 17 April 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 7.9%. Within top quartile of German dividend payers (4.7%). Higher than average of industry peers (3.4%).
Reported Earnings • Mar 03Full year 2022 earnings released: CA$0.051 loss per share (vs CA$0.10 profit in FY 2021)Full year 2022 results: CA$0.051 loss per share (down from CA$0.10 profit in FY 2021). Revenue: CA$1.22b (flat on FY 2021). Net loss: CA$4.51m (down 150% from profit in FY 2021). Revenue is forecast to grow 1.9% p.a. on average during the next 2 years, compared to a 4.2% growth forecast for the Healthcare industry in Germany. Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
